Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers [Phase 1]
Nuvectis Pharma reports a Phase 1 clinical trial of NXP-900 in subjects with advanced cancers is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Occupational Situation and Return to Work of Urological Patients
A clinical trial from Jagiellonian University is evaluating return-to-work and occupational outcomes in urological cancer patients. The stud…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: IDOV-Immune for Advanced Solid Tumors [Phase 1]
This report summarizes a Phase 1 trial of IDOV-Immune from ViroMissile, Inc. for advanced solid tumors, which is currently recruiting across…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer [Phase 1]
This update describes an ongoing Phase 1 trial evaluating interstitial brachytherapy for unresectable renal cell carcinoma (kidney cancer). …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Lu-177 PSMA Treatment in Cell Renal Carcinoma [Phase 3]
A Phase 3 clinical trial evaluating Lu-177 PSMA therapy for metastatic renal cell carcinoma is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating pazopanib hydrochloride in combination with bevacizumab for previously untreated metastatic renal cell…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer [Phase 1]
Phase 1 clinical trial evaluating nivolumab and ipilimumab, with or without the EXL01 live biotherapeutic product, for metastatic renal cell…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
A Mayo Clinic-led clinical trial is evaluating whether tumor-derived extracellular vesicles can noninvasively classify different kidney canc…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Video Education With Result Dependent dIsclosure [NA]
A Dana-Farber Cancer Institute clinical trial update for a study on video education with result-dependent disclosure, currently recruiting, …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: 177LuPSMA in Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating Lutetium-177 labeled PSMA radioligand (177Lu-PSMA) in advanced renal cell carcinoma. The study is currently active …
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors [Phase 2]
A Phase 2 clinical trial is evaluating hyperpolarized 13C pyruvate MRI as a biomarker to predict aggressiveness of renal tumors. The study i…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: 89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 imaging trial evaluating 89Zr-DFO-Atezolizumab with PET/CT in locally advanced or metastatic renal cell carcinoma is currently recru…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma [Phase 2]
Phase II trial evaluating a combination of anti-PD-1 therapy and aldesleukin (IL-2) for metastatic melanoma and metastatic renal cell carcin…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation [Phase 2]
A Phase 2 clinical trial evaluating contrast-enhanced ultrasound imaging to diagnose recurrent renal cell carcinoma after ablation is curren…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
This ClinicalTrials.gov entry describes a study by A2 Biotherapeutics evaluating HLA LOH analysis and apheresis for CAR-T cell manufacturing…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study [Phase 2]
A Phase 2 trial (The Knight SHIFT Study) is comparing morning versus afternoon administration of immunotherapy for advanced or metastatic so…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma [Phase 2]
An active Phase 2 Roche-sponsored trial is evaluating combinations of an immune checkpoint inhibitor with Axitinib in untreated locally adva…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A) [Phase 1, Phase 2]
Clinical trial update for MK-3475-03A, a Phase 1/2 study of immune and targeted therapy combinations in first-line renal cell carcinoma, spo…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma
This clinical trial update describes a prospective outcomes database to assess how the therapy landscape for Metastatic renal cell carcinoma…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial [Phase 2]
A Phase 2 clinical trial of a combination immunotherapy for advanced renal cell carcinoma is currently suspended.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
This clinical trial update analyzes clinical outcomes and genomic data from American Indian patients across several cancer indications, with…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy, being studied in advanced or metastatic solid tumors. The study is …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Study of Ward Admissions for Haematuria
This clinical trial update shows a study on ward admissions for patients with haematuria that is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery [Phase 3]
A Phase 3 trial comparing spinal morphine with intravenous lidocaine for anesthesia in robot-assisted upper urologic surgery is currently re…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer [Phase 3]
This is a Phase 3 clinical trial update indicating plans to add a biotherapy or placebo to standard treatment for advanced or metastatic ren…